Viewing StudyNCT04647526



Ignite Creation Date: 2024-05-06 @ 3:28 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04647526
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-19
First Post: 2020-11-23

Brief Title: Study Evaluating mCRPC Treatment Using PSMA Lu-177-PNT2002 Therapy After Second-line Hormonal Treatment
Sponsor:
Organization: POINT Biopharma a wholly owned subsidiary of Eli Lilly and Company